P. Jiménez

发表

Promyelocytic leukemia (PML) nuclear bodies are disorganized in colorectal tumors with total loss of major histocompatibility complex class I expression and LMP7 downregulation.

A. Concha, F. Garrido, C. Cabrera, 2004, Tissue antigens.

The Role of Toll-Like Receptor Polymorphisms in Acute Pancreatitis Occurrence and Severity

E. Redondo-Cerezo, J. de Teresa, P. Jiménez, 2014, Pancreas.

A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line

F. Garrido, M. López-Nevot, P. Jiménez, 2001, Immunogenetics.

Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.

F. Garrido, C. Cabrera, P. Jiménez, 2003, Tissue antigens.

Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2005, International journal of cancer.

Co-mutated CALR and MPL driver genes in a patient with myeloproliferative neoplasm

P. Jiménez, F. Ruiz-Cabello, M. Jurado, 2017, Annals of Hematology.

Tumor genetic alterations and features of the immune microenvironment drive myelodysplastic syndrome escape and progression

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2019, Cancer Immunology, Immunotherapy.

Genomic loss of HLA alleles may affect the clinical outcome in low-risk myelodysplastic syndrome patients

Javier Martín, F. Garrido, M. Kerick, 2018, Oncotarget.

Involvement of the chaperone tapasin in HLA‐B44 allelic losses in colorectal tumors

F. Garrido, M. López-Nevot, C. Cabrera, 2005, International journal of cancer.

In vivo and in vitro generation of a new altered HLA phenotype in melanoma‐tumour‐cell variants expressing a single HLA‐class‐I allele

J. Zeuthen, F. Garrido, L. Real, 1998, International journal of cancer.

Different mechanisms can lead to the same altered HLA class I phenotype in tumors.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2007, Tissue antigens.

Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression

A. Concha, F. Garrido, L. Real, 2000, Cancer Immunology, Immunotherapy.

β2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors

M. R. Oliva, F. Garrido, P. Jiménez, 2000, International journal of clinical & laboratory research.

Complete Loss of Hla Class I Antigen Expression on Melanoma Cells: a Result of Successive Mutational Events Publication of the International Union against Cancer

D. Schadendorf, F. Garrido, A. Sucker, 2022 .

Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors

F. Garrido, L. Real, P. Jiménez, 1999, International journal of cancer.

Expression of HLA G in human tumors is not a frequent event

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 1999, International journal of cancer.

TH1 and TH2 Cytokine Profiles as Predictors of Severity in Acute Pancreatitis

E. Redondo-Cerezo, P. Jiménez, F. Ruiz-Cabello, 2018, Pancreas.

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2009, Human immunology.

Multiple mechanisms of immune evasion can coexist in melanoma tumor cell lines derived from the same patient

J. Zeuthen, F. Garrido, L. Real, 2001, Cancer Immunology, Immunotherapy.

Analysis of HLA-E expression in human tumors

D. Geraghty, F. Garrido, P. Jiménez, 2003, Immunogenetics.

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line.

F. Real, G. Berrozpe, F. Garrido, 1996, Tissue antigens.

Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression.

F. Garrido, L. Real, P. Jiménez, 1999, Experimental hematology.

Molecular and flow cytometry characterization during the follow‐up of three simultaneous lymphoproliferative disorders: Hairy cell leukemia, monoclonal B‐cell lymphocytosis, and CD4++/CD8+/−dim T‐large granular lymphocytosis—A case report

M. González, P. Jiménez, F. Ruiz-Cabello, 2011, Cytometry. Part B, Clinical cytometry.

Major Histocompatibility Complex Class I Chain-Related α (MICA) STR Polymorphisms in COVID-19 Patients

M. López-Nevot, P. Jiménez, F. Ruiz-Cabello, 2022, International journal of molecular sciences.

Multiple mechanisms underlie HLA dysregulation in cervical cancer.

P. Stern, A. Little, F. Garrido, 2000, Tissue Antigens.

Incidence, Management Experience and Characteristics of Patients with Giardiasis and Common Variable Immunodeficiency

J. M. García-Aznar, M. López-Nevot, P. Jiménez, 2022, Journal of clinical medicine.

Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2007, BMC Cancer.

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

F. Brasseur, M. R. Oliva, T. Boon, 1998, Tissue antigens.

Microsatellite instability in cervical intraepithelial neoplasia.

A. Concha, F. Garrido, L. Real, 1998, Journal of experimental & clinical cancer research : CR.

Negative Clinical Evolution in COVID-19 Patients Is Frequently Accompanied With an Increased Proportion of Undifferentiated Th Cells and a Strong Underrepresentation of the Th1 Subset

F. Garrido, P. Anderson, P. Jiménez, 2020, Frontiers in Immunology.

Association between Genetic Polymorphisms of Inflammatory Response Genes and Acute Pancreatitis

Javier Martín, E. Redondo-Cerezo, P. Jiménez, 2019, Immunological investigations.

Characterization of HLA class I altered phenotypes in a panel of human melanoma cell lines

G. Pawelec, F. Garrido, P. Jiménez, 2008, Cancer Immunology, Immunotherapy.

Unresponsiveness to interferon associated with STAT1 protein deficiency in a gastric adenocarcinoma cell line

F. Garrido, L. Real, P. Jiménez, 1998, Cancer Immunology, Immunotherapy.

Acute Myeloid Leukaemia of Donor Cell Origin Developing 17 Years after Allogenic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukaemia

J. Lorente, P. Jiménez, F. Ruiz-Cabello, 2012, International journal of biomedical science : IJBS.

A mutation determining the loss of HLA-A2 antigen expression in a cervical carcinoma reveals novel splicing of human MHC class I classical transcripts in both tumoral and normal cells

P. Stern, F. Garrido, P. Jiménez, 2000, Immunogenetics.

GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

Matthew A. Wiles, Ellen C. Smith, Jack D. Sanders, 2023, Nature.

Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia

M. Cuadros, P. Jiménez, M. Camós, 2019, Blood Cancer Journal.

Complete loss of HLA class I antigen expression on melanoma cells: A result of successive mutational events

D. Schadendorf, F. Garrido, A. Sucker, 2003, International journal of cancer.

Changes in activatory and inhibitory natural killer (NK) receptors may induce progression to multiple myeloma: implications for tumor evasion of T and NK cells.

F. Garrido, P. Jiménez, F. Ruiz-Cabello, 2009, Human immunology.